Biologic agents are an emerging treatment option for COPD. Biologic agents have been recently approved for use by NICE but how will the system respond to meet this implementation challenge and what does this mean for you in practice? This session will explore and discuss this for respiratory care.

Practice nurses are ideally placed to support patients who smoke, but starting the conversation can sometimes feel difficult. In the session we will:

• • explore how to raise smoking in a positive, non-judgemental way, using the principles of Very Brief Advice to encourage quit attempts and improve referrals into local stop smoking services.
• • look at the language that can help these conversations flow, common concerns and patient responses, and how practice nurses can offer effective support without needing to be stop smoking specialists
• • include a vape myth-busting some of the most common misconceptions.
  

The session explains FeNO testing within asthma diagnosis and management, focusing on when FeNO testing is appropriate, how results should be interpreted alongside clinical assessment, and how FeNO aligns with NICE, BTS and SIGN asthma guidance to support evidence-based decision making.

The session will highlight how FeNO measurement can support earlier diagnosis, more confident treatment decisions and improved monitoring. It will also provide an overview of recommended next steps following FeNO testing, outlining how results feed into current asthma treatment pathways, including initiation, optimisation or review of therapy in line with the latest UK guidance.

Health inequalities significantly impact respiratory care, driving disparities in disease prevalence, diagnosis, and clinical outcomes across socio-economically disadvantaged populations. This session explores how targeted interventions can dismantle these barriers to deliver equitable, patient-centred care. We will examine the critical roles of ethnicity, environmental injustices, and socioeconomic deprivation in exacerbating conditions like asthma and COPD. Attendees will gain actionable insights into implementing culturally tailored interventions, optimising digital health accessibility, and strengthening community-based outreach. By addressing these structural root causes, healthcare professionals can actively narrow the equity gap, improve treatment adherence, and ensure optimal respiratory health outcomes for all individuals.